Gleason Grade – impact on adjunct treatments

08 Feb 2012

In research recently accepted for publication in the British Journal of Urology International, Dr Stricker - as part of a team of Australian health professionals at the Garvan Institute of Medical Research and St Vincents Prostate Cancer Centre - looked at the way in which the type of cancer at the edges of a removed tumour effect the cancer re-occurrence rate and may guide future treatments. Drs James Kench and Dr Richard Savdie were senior authors whilst Dr Stricker treated the majority of patients.

Robotic Surgery – focus now on 5 outcomes

02 Feb 2012

St Vincent's Prostate Cancer Centre, as Chaired by Dr Phillip Stricker, is one of five international sites to engage in a study to assess the pentafecta. The pentafecta is a new concept used to report outcomes of minimally invasive robotic surgery and was championed by Vip Patel.

Traditionally surgeons viewed robotic surgery outcomes in terms of the trifecta – cure, continence and potency. However, the pentafecta encompasses two post surgery outcomes – lack of complications and negative surgical margins; that is the absence of cancer in the edges of the removed tumour.

Biopsy - transperineal versus transrectal

24 Jan 2012

Safe and accurate biopsies are essential to the management of prostate cancer. Whilst the transrectal biopsy is more common in Australia, transperineal biopsy potentially has a lower risk of infection rate and better detection of anterior-based tumours. As a leader in the care of men with prostate cancer and a world initiator of the transperineal technique, Dr Stricker has analysed safety outcomes and detection rates in the transperineal technique with comparison against a USANZ audit of the transrectal technique and a large international series. The findings indicate that the transperineal biopsy is safer and more accurate.

7.30 Report: Prostate surgery under the microscope

21 Jan 2012

Reporter Natasha Johnson's story, 'Prostate surgery under the microscope', looks at the use of robotic surgery in prostate cancer and the research that compares it to traditional open surgery. Leading prostate specialists give their views.